Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Exchange Rate Effect (2017 - 2025)

Historic Exchange Rate Effect for Vanda Pharmaceuticals (VNDA) over the last 9 years, with Q3 2025 value amounting to -$180000.0.

  • Vanda Pharmaceuticals' Exchange Rate Effect fell 36470.59% to -$180000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$199000.0, marking a year-over-year decrease of 20529.1%. This contributed to the annual value of -$163000.0 for FY2024, which is 44680.85% down from last year.
  • According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Exchange Rate Effect is -$180000.0, which was down 36470.59% from $134000.0 recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Exchange Rate Effect ranged from a high of $183000.0 in Q4 2022 and a low of -$202000.0 during Q4 2024
  • Its 5-year average for Exchange Rate Effect is $3210.5, with a median of -$14000.0 in 2021.
  • In the last 5 years, Vanda Pharmaceuticals' Exchange Rate Effect tumbled by 94166.67% in 2021 and then soared by 99333.33% in 2025.
  • Vanda Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$101000.0 in 2021, then soared by 281.19% to $183000.0 in 2022, then fell by 18.03% to $150000.0 in 2023, then crashed by 234.67% to -$202000.0 in 2024, then grew by 10.89% to -$180000.0 in 2025.
  • Its last three reported values are -$180000.0 in Q3 2025, $134000.0 for Q2 2025, and $49000.0 during Q1 2025.